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The Relationship between Selected Nutrients and Depression among Smokers 
I. Introduction  
In 2006, 20.2% of Americans were classified as cigarette smokers, with a median smoking 
prevalence of 22.2% for men and 18.5% for women. Every year, more than 438,000 Americans die 
from smoking cigarettes even though smoking remains the most preventable cause of death in the 
United States (MMWR, 2007).  According to the Surgeon General’s Report regarding the health 
consequences of cigarette smoking, smoking causes a variety of diseases and harms every organ of 
the body.  Despite this, the Surgeon General states that quitting smoking has immediate benefits 
and can ultimately reduce the risk of developing these diseases (U.S. Department of Health and 
Human Services, 2004).  Because of these findings, research regarding the co-occurring problems 
that smokers face, such as depression and nutritional deficits, is a necessity. 
It is estimated that millions of Americans suffer from depression, leading to both physical and 
psychological ailments (NASD, 2002). While the cause of depression remains unclear, it has been 
proposed that many factors influence the occurrence of depressive symptoms (Brown, Madden, 
Palenchar, & Cooper-Patrick, 2000).  In recent studies, a correlation has been found between 
smoking status and depressive symptoms with an increased prevalence of depressive symptoms 
among smokers, especially among women (Brown, Madden, Palenchar, & Cooper-Patrick, 2000; 
Son, Markovitz, Winders, & Smith, 1997). In addition to this, it has also been shown that depressive 
symptoms have a negative impact on the smoker’s ability to quit smoking (Brown, Madden, 
Palenchar, & Cooper-Patrick, 2000), thus leading to further health problems.  This has important 
implications in clinical practice because it indicates the need to further investigate the relationship 
between smoking and other factors that may further intensify the health risks that smokers face.    
Of the factors influencing depression, diminished serotonergic (5-HTergic) function is a 
widely accepted theory that is attributed to the onset and course of depression. The 5-HTergic 
system is complex and thus has a variety of clinical implications. While most of the cell bodies of 5-
HTergic neurons are located in the raphe nuclei in the brain stem, the axons of these neurons 
innervate almost the entire brain. While the exact function of 5-HT has been difficult to define, it is 
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known that 5-HT is generally an inhibitory neurotransmitter involved with mood, anxiety, and sleep 
induction.  Although strong connections between 5-HT and depression have been revealed, not all 
patients who have diminished 5-HTergic function show depressive symptoms and not all people with 
depressive symptoms have diminished 5-HTerigic function.  Because of this, diminished 5HT is 
described as being a vulnerability factor in developing depression (Jans, Riedel, Markus, Blokland, 
2007).  
A variety of factors have been attributed to altered 5-HT function (Jans, Riedel, Markus, 
Blokland, 2007).  Studies in the past have indicated that low levels of tryptophan, an essential amino 
acid required to produce both vitamin B3 (niacin) and 5-HT via an enzyme called tryptophan 
hydroxylase, have been found in people who exhibit depressive symptoms (Coppen, Eccleston, 
Craft & Bye, 1973; Cowen, Parry-Billings & Newsholme, 1989). Vitamin B6 (pyridoxine) is required 
for the conversion of tryptophan to niacin and serotonin. When vitamin B6 is deficient, the body 
cannot complete this conversion and the body then excretes compounds that are not fully 
metabolized.  In addition to this, it is important to note that tryptophan converts to niacin before 
serotonin.  If a person has a niacin deficiency, the body will use the tryptophan to make niacin to 
address the deficiency and not convert to serotonin, thus leading to a serotonin deficit (Kline, 2006). 
Smoking is thought to decrease these conversions. Because of this, taking niacin and pyridoxine 
intake into consideration is important when examining tryptophan intake in relation to depressive 
symptoms and smoking.  
In addition to tryptophan, omega-3 polyunsaturated fatty acids (omega-3 PUFAs) have been 
proposed to influence the occurrence of depressive symptoms.  Omega-3 PUFAs, which are 
essential fatty acids, are highly concentrated throughout the brain and central nervous system and 
affect neurotransmitter synthesis. Studies have indicated an inverse relationship between 
docosahexaenoic acid (DHA), an omega-3 PUFA, and depression, thus implicating that a long-term 
low dietary intake of DHA is associated with an increased incidence of depression in adults 
(Mamalakis et al, 2006). The INTERMAP study, which examined dietary intake in male and female 
smokers versus that of ex-smokers and never smokers, indicated that smokers in general have less 
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healthful diets than nonsmokers, with a lower intake of a variety of nutrients. Among these nutrients 
are omega-3 PUFAs, fiber, vitamin C, vitamin E, beta carotene, iron, and calcium (Dyer, Elliott, 
Stamler, Chan, Ureshima & Zhou, 2003).   
It is evident that previous studies have shown that depression and nutritional alterations are 
common problems among smokers. Research has been focused on the relationships between 
depression and smoking, nutrition and smoking, and nutrition and depression, but little research has 
been designed to examine whether a relationship exists among these three variables. This 
secondary analysis aims to study the relationship between depressive symptoms among smokers 
and the intake of tryptophan, controlling for niacin and pyridoxine intake, and omega-3 PUFAs. 
Another primary aim of this study is to look at the influence nicotine dependence has on stress, 
depression, and the selected nutrients. A secondary aim of this study is to explore the relationship 
between sociodemographics, smoking level, body mass index (BMI) and depression. 
 
II. Review of Literature  
 Literature searches were conducted on Medline and PubMed to identify studies relevant to 
this hypothesized relationship among smoking, depression and selected nutrients.  In this review of 
literature, relevant studies are grouped into five categories: smoking and depressive symptoms; 
depressive symptoms and stress; omega-3 PUFAs and depressive symptoms; tryptophan, 
depressive symptoms, and smoking; and smoking and omega-3 fatty acids.   
 
Smoking and Depressive Symptoms 
 Because of the high correlation between smoking and depression, various studies have been 
designed to further examine this relationship.  In a study by Son, Markovitz, Winders, and Smith 
(1997), data from the Coronary Artery Risk Development in Young Adults (CARDIA) Study was used 
to examine whether depressive symptoms were independently associated with smoking and nicotine 
dependence among cigarette smokers.  The sample consisted of 3,933 participants ages 23-35.  
Black men, black women, white men, and white women were represented in this study.  The Center 
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for Epidemiologic Studies Depression (CES-D) Scale (Radloff, 1977) was used to measure the 
severity of depressive symptoms, while nicotine dependence and cigarette smoking status was 
determined through a questionnaire administered by an interviewer.  A serum cotinine level of 
greater than or equal to 19 ng/ml was used to confirm smoking status.  Nicotine dependence was 
measured by the amount of time prior to the participant smoking his or her first cigarette of the day 
with dependence defined as smoking a cigarette within 30 minutes of arising. Results indicated that 
depressive symptoms were more prevalent among smokers; however, this relationship was not 
statistically significant among white men.  When nicotine dependence was taken into consideration, 
the dependent smokers in all the groups showed higher CES-D scores.   
 The results of this study validate the correlation between smoking and depression with a 
higher occurrence of depressive symptoms among those who are nicotine dependent.  This study 
does not address the possibility that people take up smoking because they are depressed.  In 
addition, the researchers used only one question to define nicotine dependence. Despite these 
limitations, although this study is cross-sectional in nature, its large sample size and statistically 
significant findings make it both reliable and valid.  It is a well designed study that validates that 
smoking is related to depressive symptoms.   
 Like the previous study discussed, Brown, Madden, Palenchar, and Cooper-Patrick (2000) 
also aimed to further examine the relationship between depressive symptoms and smoking.  In their 
study, 526 people aged 18-64 were recruited in the waiting room of various urban primary care 
offices.  Although this sample is not as large as the sample in the CARDIA study, it includes both 
older and younger populations.  Like the CARDIA study, the CES-D scale was used to measure 
depressive symptoms. Smoking status was measured using questions from a modified version of the 
Fagerstrom Test for Nicotine Dependence.  The number of cigarettes smoked per day and the time it 
takes for the patient to smoke their first cigarette of the day were used to measure nicotine 
dependence.  Similar to the CARDIA study, this study found that the severity of depressive 
symptoms increased with nicotine dependence.   
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 While the Brown et al study further validates the fact that smoking is correlated with 
depressive symptoms, the participants did not represent the general population.  The participants 
were primarily white females less than 50 years of age, who were educated beyond high school and 
had steady employment.  In addition, validation of smoking status was based on self-report 
measures.  This study failed to take into consideration other factors that could influence depressive 
symptoms. This is especially important because the participants in this study were seeking medical 
attention.  The medical conditions of the participants could have had a great deal of influence on the 
severity of the depressive symptoms reported.  Despite these limitations, the major findings of this 
study are congruent with the CARDIA study.  This further emphasizes the correlation between 
smoking and depressive symptoms.   
 Another recent study by Kenney, Holahan, North, and Holahan (2006), sought to examine 
this relationship, but did not take nicotine dependence into consideration.  This study, which utilized 
the data from the National Survey of Midlife Development in the United States, examined 2,087 
American workers.  The researchers measured depression using their own questions, which 
resembled a modified Beck Depression Inventory (Kenney et al, 2006). They measured smoking 
status by classifying the participant as a current smoker, a current nonsmoker, a past smoker, or a 
past nonsmoker.  The results of this study validate the researchers’ initial hypothesis that the level of 
depressive symptoms predicted smoking status. Unlike the CARDIA study, smoking status was 
determined through self report measures.  In addition to this, the cross-sectional nature of this study 
is a limitation.  However, the large sample size and statistical significance of the results increase the 
reliability and validity of the findings.   
While the three studies discussed all have limitations, it is evident from their findings that 
there is a relationship between smoking and depressive symptoms.  The Kenney et al study did not 
need to take nicotine dependence into account in order to achieve a statistically significant 
correlation between smoking and depressive symptoms.  This contradicts the findings of the 
CARDIA study, in which nicotine dependence needed to be considered in order for the results to be 
statistically significant.  Further studies that take these limitations into consideration are needed. A 
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study in which racial and age groups are equally represented and does not completely rely on self-
report measures for smoking status would further enhance the understanding of the relationship 
between smoking and depressive symptoms.    
 
Stress and Smoking 
 A recent study by Croghan, Bronars, Patton, Schroeder, Nirelli, & Thomas, et al (2006) 
sought to examine the relationship between body image, smoking, stress, and self-esteem. While it 
is unknown if negative mood precedes smoking or visa versa, studies have shown that smokers use 
smoking as a form of self-medication. Negative mood, also known as negative affect, includes 
symptoms such as stress, anger, sadness, distress, and low self-esteem. Croghan et al sought to 
identify these factors among young adults and determine if they are related to smoking status. 
Researchers in this study used a convenience sample of 1456 students between the ages of 18 and 
24 at three Midwestern universities. Of the 1456 participants, 483 were smokers and 973 were 
nonsmokers. Participants were invited to take a self-administered survey that included items from 
the Body-Areas Satisfaction Scale (BASS), Perceived Stress Scale (PSS), Rosenberg Self-Esteem 
Scale (SE), and Positive and Negative Affect Schedule (PANAS), as well as questions regarding 
tobacco use and lifestyle choices (Croghan et al, 2006). 
 The results from this study indicate that smokers had higher levels of stress and lower self-
esteem. In addition, multiple logistic regression analyses indicated a strong association between 
stress and smoking status, but not smoking status and negative affect. Researchers concluded that 
this may be due to the fact that negative affect may be a mediator of stress and smoking. It is also 
important to consider that these findings are limited due to self-report and researchers only focused 
on the young adult population, most of whom were white. Despite these limitations, the large sample 
size and statistically significant findings validate the notion that smoking, negative affect, and stress 
are related and warrant further study (Croghan et al, 2006).  
 Another study by File, Dinnis, Heard, and Irvine (2002) sought to examine sex differences in 
mood between light smokers and nonsmokers. The participants in the study included 36 students in 
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Great Britain. The subjects included 9 female smokers, 9 female nonsmokers, 8 male smokers, and 
10 male nonsmokers. The smokers smoked 5-12 cigarettes per day for at least one year. Baseline 
anxiety and depression were measured using the Hospital Anxiety and Depression Scale. Mood and 
aggression baseline data were also collected. Testing was scheduled for each smoker at a time 
when they usually smoked and testing began 5 minutes after smoking. Volunteers were then shown 
20 images, each for 3 seconds, and then were asked to recall as many as possible 20 minutes after 
viewing the images. Subjects were then asked to complete a digit-symbol substitution test while 
counting gaps in music that played in the background in order to measure psychomotor speed and 
attention. Other cognitive tests that were administered included matching tests and an Auditory 
Serial Addition Test (File et al, 2002).  
 Results indicated that smokers, who smoked 5 minutes before testing, were more likely to 
feel dizzy and had greater symptoms of sweating and dry mouth during the protocol. In addition 
smokers were significantly more discontented, troubled, tense, and slow. There was also significant 
data that supported the hypothesis that smokers were more furious, impatient, unfriendly, annoyed, 
and disgusted after completing the tests. The cognitive tests also caused smokers increased stress 
and decreased attention when compared with nonsmokers and there were no significant differences 
between genders. Despite these findings, the smokers performed better on the memory tests. 
Researchers concluded that these results are most likely a result of both genetic factors and the 
direct effects of nicotine, mediated by the 5-HT system (File et al, 2002).  
 Limitations of this study include the small sample size and the fact that the study design did 
not allow the researchers to determine whether the mood differences observed between the 
smokers and nonsmokers were due to the long-term effects of nicotine. In addition, abstinent state 
was not observed in the smoking group. Despite these limitations, this study provides strong 
evidence that supports the association between smoking and stress and suggests the need for 
further research on this topic (File et al, 2002).  
  
Omega-3 PUFAs and Depressive Symptoms 
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 Various studies have been designed to determine if a relationship exists between the intake 
of polyunsaturated fatty acids and depressive symptoms. A recent study by Mamalakis, 
Kalogeropoulos, Andrikopoulos, Hatzis, Kromhout, Moschandreas, et al. (2006) found an inverse 
relationship between depression and long chain n-3 PUFAs in a sample of 130 healthy adults from 
Crete.  This is the first study designed to examine this relationship in a non-homogenous sample 
using these methods.  Researchers used a Greek translation of the Zung Self-rating Depression 
Scale (ZSDS) to measure the level of depression (Fontoulakis et al, 2001).  Adipose tissue samples 
were collected by aspirating subcutaneous buttock tissue.  Adipose tissue fatty acid composition is a 
biomarker that indicates dietary fat intake over a one to three year period.  The study’s results 
suggest that the inverse relationship between depression and n-3 long chain fatty acids indicates a 
lower dietary intake of these fatty acids over time.  Mamalakis, et al hypothesize that this relationship 
is due to the fact that fatty acids inhibit pro-inflammatory cytokine synthesis, which is associated with 
depression, by suppressing inflammation and immune reactivity markers. 
 Despite these findings, the Mamalakis, et al study does have limitations.  Because this study 
is a cross-sectional design, the findings cannot be used to imply that there is a cause-effect 
relationship between depression and fatty acid intake.  In addition to this, the study was composed 
of mostly non-depressed subjects.  Mamalakis, et al do state that studies such as this have not yet 
been conducted in the depressed population. These limitations provide future aspects to consider for 
further research on this topic.   
 Another study, by Kiecolt-Glaser, Belury, Porter, Beversdorf, Lemeshow, and Glaser (2007), 
also aimed to investigate the relationship between depressive symptoms and fatty acid intake.  
However, this particular study aimed to examine the relationship between PUFA levels and 
depressive symptoms in relation to the cytokine synthesis involved in inflammation.  The sample in 
this study consisted of 43 older adults with a median age of 66.7 years.  Depressive symptoms were 
measured using the CES-D Scale and immunological assays and fatty acid analyses were used to 
measure cytokine and fatty acid levels. Despite the small sample size and cross-sectional nature of 
this study, results indicate that a higher ratio of omega-6:omega-3 fatty acids was correlated with 
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higher levels of depressive symptoms, both of which increase proinflammatory cytokine levels.  This 
is because a higher omega-6:omega-3 ratio suggests that there is a lower level of omega-3 intake.  
The Keicolt-Glaser, et al study used serum PUFA levels instead of the tissue aspiration method used 
in the Mamalakis, et al study. Despite this, both studies indicate that there is an inverse relationship 
between the dietary consumption of PUFAs and depressive symptoms in adults.   
 Although the two previously discussed studies have shown results implying this relationship, 
a study by Hakkarainen, Partonen, Haukka, Virtamo, Albanes, and Lönnqvist (2004) found no 
relationship between mood level and dietary intake of omega-3 fatty acids.  In this study, the sample 
consisted of 29,133 men ages 50-69 in Finland. Data were used from the previously conducted 
ATBC Cancer Prevention Study, which was a randomized, double-blind, placebo-controlled study.  
Although this study was well designed, the measurements used in the Hakkarainen, et al study 
significantly weaken the results.  Depressive symptoms were measured by asking the participants if 
they felt symptoms of depressed mood or anxiety and were recorded three times per year.  History 
of major depression and suicide, as it appeared on a death certificate, were also taken into 
consideration.  Omega-3 fatty acids were measured by a food frequency questionnaire that asked 
the participants to recall their dietary intake over a year.  There was no scale used to measure 
depressive symptoms and no patient history was taken into consideration besides history of 
treatment for depressive symptoms and the presence of suicide on a death certificate.  Although the 
randomized, double-blind, placebo-controlled design of this study is stronger than the Mamalakis, et 
al and the Keicolt-Glaser, et al study, the measures were weaker overall.  Because of this, it is 
inconclusive whether or not there is a relationship between omega-3 fatty acids and depressive 
symptoms.  More research needs to be completed in this area before a true relationship can be 
confirmed.   
 
Tryptophan, Depressive Symptoms, and Smoking  
Similarly, there has been a hypothesized inverse correlation between tryptophan levels and 
depression, with smoking exacerbating this relationship. To first address the link between tryptophan 
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and depression, tryptophan is an essential amino acid that plays a vital role in brain processes.  Both 
vitamin B3 (niacin) and the neurotransmitter serotonin are synthesized in the brain from tryptophan, 
with the help of vitamin B6 (pyridoxine).  Tryptophan, being an essential amino acid, must be 
supplied to the body through dietary intake.  Because of this, according to the Booij, et al (2005) 
study, acute tryptophan depletion (ATD) is a method that displays the effects of decreased levels of 
serotonin in the brain in 50-60% of patients who are depressed and taking serotonergic 
antidepressants to treat their depression.  This is because depleting tryptophan levels ultimately 
depletes serotonin and diminished serotonin levels are highly associated with depression. Because 
of this relationship, ATD in experimental conditions causes these patients to display symptoms of 
relapse in their depressive symptoms even while on medication.   
The added element of smoking in this relationship was recently publicized.  A recent study by 
Spring, et al (2007), reported that smoking magnified this ATD response in those with a history of 
major depression.  Researchers recruited a total of 73 subjects with and without histories of smoking 
and major depression.  A 21-item Hamilton Depression scale was used to evaluate level of 
depression and personal and familial history of depression were obtained (Hamilton, 1967).  
Smoking was defined as smoking more than ten cigarettes per day for at least one year.  In order to 
have a history of major depression, personal and familial major depressive disorder was necessary.  
All subjects followed a low tryptophan diet and smokers were encouraged to smoke regularly in 
order to prevent nicotine withdrawal during the acute study.  One group was given a placebo, while 
the other group was given an ATD drink to decrease tryptophan levels in the body. Five hours after 
being given the drinks, the subjects were exposed to negative guided imagery and mood was 
assessed.  Results demonstrated that smoking heightened depressive symptoms in response to 
acute reduced tryptophan in subjects with a history of major depressive disorder (Spring, et al, 
2007).   
A double-blind study by Pergadia, Spring, Konopka, Twardowska, Shirazi, & Crayton (2004) 
reported similar findings.  Seven smokers with and without a history of depression participated, were 
recruited via advertisements, and smoked an average of 18.9 cigarettes per day.  The subjects were 
Nutrition and Depression 12 
asked to consume a tryptophan-depleting drink or a similar tasting placebo on two days separated 
by a one week interval.  Following consumption, they were asked to sit in a waiting area and were 
allowed to read neutral material and smoke as they pleased.  Five hours after consumption, 
participants listened to negative material via headphones. They were asked to respond to a Modified 
Hamilton Rating Scale for Depression (Hamilton, 1960) at three, five, and seven hours after 
consumption of the drinks.  To be sure that the participants were smoking as usual, exhaled carbon 
monoxide levels were taken every two hours.  Brain scans were also completed during the testing 
period.  Despite the extremely small sample size, the Pergadia, et al study concluded that 
tryptophan depletion caused depressed mood in smokers with and without a history of major 
depression.  Although these findings differ slightly from the Spring et al study in which depressed 
mood was only seen in smokers with a history of depression, they verify the relationship between 
tryptophan, depression, and smoking.   
 
Smoking and Omega-3 Fatty Acids 
 Various studies have aimed to look at smoking and nutrition.  In recent analyses, smokers 
have been determined to have less than adequate dietary intakes of a variety of nutrients.  A recent 
study by Dyer, Elliott, Stamler, Chan, Ureshima & Zhou (2003), examined the diet of smokers in 
relation to nonsmokers.  This study examined the dietary intake in 4680 participants in four countries 
using data from the INTERMAP study, which is an epidemiologic study that examined the 
relationship between nutrients and other dietary factors.  Using 24-hour recalls, this study indicated 
that smokers in general have less healthful diets than nonsmokers, with a lower intake of a variety of 
nutrients, such as omega-3 PUFAs, fiber, vitamin C, vitamin E, beta carotene, iron, and calcium.  
This study reports that these findings are consistent with many previous studies that have aimed to 
examine the relationship between select nutrients and smoking status.  
 A study by Marangoni, Colombo, DeAngelis, Cambaro, Agostoni, Giovannini, and Galli 
(2004) aimed to look at the metabolic aspect of this problem in a cellular model.  Researchers used 
healthy human mammary gland cells and observed their characteristics under normal conditions.  
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Cigarette smoke was introduced to these cells through aspiration and a pump.  Interpretation of this 
data indicates that cigarette smoke negatively affects omega-3 fatty acid synthesis.    
 Another study by Pawlosky, Hibbeln, & Salem (2007), characterized a broader aspect of the 
relationship between omega-3 PUFAs and smoking.  Because smoking increases circulating free 
radicals and polyunsaturated fatty acids (PUFAs) have been determined to be highly susceptible to 
free radical oxidation, it has been hypothesized that chronic smoking may decrease the amount of 
PUFAs in plasma and red blood cells. The study by Pawlosky et al (2007) examined the effects of 
smoking on omega-3 fatty acid metabolism in 5 female nonsmokers, 5 female smokers, 5 male 
nonsmokers, and 5 male smokers. For 3 weeks, subjects ate a beef-based diet provided by the 
research kitchen.  During the final week of the study, after an overnight fast, subjects were 
administered 1 g of -Linolenic acid, the most abundant omega-3 fatty acid in the North American 
diet, in low fat yogurt prior to their morning meal.  With the exception of the 8 hour sample, 40 mL of 
blood was taken at 24, 48, 72, 96, and 160 hours under fasting conditions.  Plasma fatty acids were 
analyzed using gas chromatography and GC-mass spectrometry and concentration-time curves 
were used to assess kinetic rate parameters.  Results from the study showed that smoking 
accelerated the metabolism of omega-3 fatty acids.  These findings suggest that smokers would 
therefore need to consume more omega-3 fatty acids than nonsmokers.   
 Although the sample size of the Pawlosky et al (2007) study was relatively small, it further 
examined the relationship suggested by Marangoni et al (2004).  Because of the results implied by 
these two studies, it may be suggested that two factors play into the lower omega-3 fatty acid levels 
in smokers.  The first of these factors is that smokers tend to consume less omega-3 fatty acids than 
nonsmokers.  The second of these factors is that cigarette smoke alters PUFA synthesis because of 
the free radicals that result from smoking, thus affecting PUFA metabolism on the cellular level.  
Because of these findings, studying the general relationship between smoking and omega-3 fatty 
acid intake is essential in order to determine the implications of this relationship.  The added impact 
of the inverse relationship between depression and long chain n-3 PUFAs may also affect these 
variables. 
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Conclusion 
 The studies presented in this review of literature imply that various relationships exist 
between smoking, depression, stress and the selected nutrients.  Research has demonstrated an 
increased incidence of depressive symptoms and stress among smokers across both genders and 
all races.  In general, studies have indicated that smokers have less than adequate intake of a 
variety of nutrients, especially omega-3 fatty acids and tryptophan, which have been shown to have 
an inverse relationship with depressive symptoms. Because there is no research regarding the 
interaction of smoking, depression, stress, and these selected nutrients, this secondary analysis 
aims to study the interactions between these four variables.  
 
III. Methods: 
 This secondary analysis aims to analyze four main research questions: (1) What is the 
relationship between depressive symptoms among smokers and the intake of tryptophan, controlling 
for niacin and pyridoxine intake? (2) What is the relationship between depressive symptoms among 
smokers and the intake of omega-3 PUFAs?  (3) Of tryptophan intake, omega-3 PUFA intake, and 
smoking level, what is the best predictor of depression?  (4) Is there a significant difference in 
tryptophan intake, omega-3 intake, depressive symptoms, and perceived stress between nicotine 
dependent smokers and non-nicotine dependent smokers? A secondary aim of this study is to 
explore the relationship between sociodemographics, smoking level, body mass index (BMI) and 
depression. 
It is hypothesized that smokers with increased depressive symptoms will have lower than the 
recommended levels of these nutrients in their diets and that nicotine dependent smokers will have 
greater depressive symptoms, higher perceived stress, and lower than the recommended dietary 
intake of tryptophan and omega-3 fatty acids. 
 
Theoretical Framework 
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 This study uses the biobehavioral approach to examine the relationship between nutrition 
and depression among smokers. This is a multidisciplinary approach that seeks to examine the 
biological and behavioral determinants of health status as well as the effects of biological and 
psychosocial influences on behavior (Kozlowski, Henningfield, & Brigham, 2001). 
 
Design 
 This study uses a descriptive, correlational design in which a correlation matrix will be used 
to determine any relationships that exist among smoking, depression, tryptophan, omega-3 PUFAs, 
and antioxidants. 
 
Participants 
 The primary study aimed to examine the effects of ethnicity and menthol/non-menthol 
cigarette preference on nicotine dependence, smoking topography, and cigarette smoke constituent 
exposure.  The inclusion criteria included 136 African American and Caucasian male or female 
smokers 18-50 years of age who identified themselves as a person who has smoked 10-40 
cigarettes/day for one year.  Women were to be in the mid to late follicular phase of the menstrual 
cycle, confirmed by progesterone levels.  Exclusion criteria included other forms of tobacco use, 
taking regular prescription medications, history of liver, endocrine or pulmonary disease, drug or 
alcohol abuse, and pregnant or lactating women.  Health status was determined upon admission via 
a detailed history and physical examination.  Recruitment of the sample in the primary study involved 
placing advertisements in neighborhood newspapers and informational flyers in work settings, 
community centers and clinics. Subjects were paid $250 to participate in the primary study.   
 
Sample Size Justification 
 For the correlational analysis involving Pearson’s r, a sample size of 85 will have an 80% 
power to detect a medium effect at =0.05.  For the multiple regression analysis with three 
predictors (smoking, tryptophan and omega-3 PUFAs), a sample size of 76 will have an 80% power 
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to detect a medium effect at =0.05. The probable sample size of 136 subjects more than satisfies 
this requirement (Cohen, 1992). 
 
Procedure 
In the primary study, adult cigarette smokers who met the inclusion criteria participated in a 
36-hour protocol at the Ohio State University Clinical Research Center (CRC).  During this time, 
measures of nicotine dependence, nicotine and carbon monoxide increases pre to post-cigarette, 
cotinine concentrations, sensory perceptions post-cigarette, and smoking topography were obtained 
while the participants smoked their usual brand of cigarettes ad lib.  Twenty-four hour urine samples 
were also obtained to analyze cigarette smoke constituents of menthol and its metabolite, tobacco 
specific nitrosamines, and polycyclic aromatic hydrocarbons. 
 
Instruments 
 For this secondary analysis, four measures were used to examine the research questions.  
The plasma nicotine and cotinine levels were assayed by high performance liquid chromatography-
tandem mass spectrometry (LC-MS/MS) at Mayo Laboratories.  The LC-MS/MS method has a 
coefficient of variation for both intra-assays and inter-assays of nicotine and cotinine ranging from 
4.9% to 11% with excellent correlations (r>0.98) to comparison methods (Moyer et al., 2002). This 
will be used to quantify level of cigarette smoking. 
The Vio Food Frequency Questionnaire (VioFFQ) was used to asses the subject’s nutritional 
intake.  Each subject completed the VioFFQ in order to obtain information regarding the types and 
quantities of foods consumed over the past 90 days.  The subject answered questions based on 
food grouping, frequency of intake, and portion size. The software used the information obtained 
from this questionnaire to estimate each subject’s daily nutrient intake over the past three months 
(Viocare Technologies, Inc).  In this secondary analysis, tryptophan, pyridoxine, niacin, omega-3, 
and antioxidant intake were analyzed.  The VioFFQ is based on information obtained from The 
Women’s Health Initiative Food Frequency (Patterson et al, 1999).  
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The Center for Epidemiologic Studies Depression Scale (CES-D) was used to assess the 
subject’s depressive symptoms.  The (CES-D) is a 20 item scale used to assess depressive 
symptomatology in the general population.  Subjects rated the severity of their depressive symptoms 
during the past week on a 4 point likert scale. This scale ranges from 0 to 3, in which 0 means the 
subject experiences the symptom rarely and 3 indicates the subject experiences the symptom most 
of the time.  The subject is given a score ranging from 0 to 60, which is the total of the 20 items with 
a score greater than or equal to 16 indicative of depressive symptomatology.  The CES-D Scale is 
found to have very high internal consistency and test- retest repeatability (Radolff, 1977). 
The Perceived Stress Scale-10 (PSS) was used to measure the degree to which the subjects 
considered situations stressful over the previous month. This is a 10-question tool scored on a 5-
point likert scale and is the only established index of general stress appraisal. It was developed by 
Cohen, Kamarck, & Mermelstein (1983) and is found to have high internal reliability (alpha=0.78). 
Higher scores on the PSS are associated with increased perceived stress and scores are also 
associated with depressive and physical symptomology (r=0.52-0.76) (Cohen et al, 1983).  
Time to first cigarette of the day (TTF) will be used to measure nicotine dependence. A study 
by Heatherton, Kozlowski, Frecker, Rickert, and Robinson (1989) performed regression analyses 
using TTF and average daily consumption of cigarettes (CPD) to predict carbon monoxide, nicotine, 
and cotinine levels. In three independent samples, subjects who had their first cigarette earlier after 
awakening had higher levels of carbon monoxide, salivary and plasma cotinine, and nicotine than 
subjects who postponed having their first cigarette. Both TTF and CPD were concluded to be 
indicative of heaviness of smoking and are the most practical, non-invasive, and powerful predictors 
of nicotine dependence (Heatherton et al, 1989).  For the purposes of this secondary analysis, 
subjects will be divided into two groups with smoking within 30 minutes of waking classifying 
subjects as nicotine dependent.  This time frame is supported by the Fagerstrom Tolerance 
Questionnaire, which measures physiological tolerance to nicotine (Fagerstrom, 1978). 
  
Human Subjects 
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IRB approval was obtained by the investigators of the primary study. 
 
Data Analysis 
 Descriptive statistics, including mean, standard deviation, and ranges, were used for 
smoking level (cotinine ng/mL), depression (CES-D), perceived stress, time to first cigarette, and 
nutrient intake.  For research questions 1 and 2, Pearson’s correlation (Pearson’s r) and Kendall’s 
Tau B were used to describe the linear relationship between smoking, depression, and the selected 
nutrients. For research question 3, multiple regressions will be used to analyze data in order to 
determine which variable best predicts depression because it allows simultaneous testing and 
modeling of the multiple independent variables present in the study. T-Tests were used to examine 
differences in smoking patterns among races and BMI differences among genders. Mann-Whitney 
tests were used to determine the difference in tryptophan intake, omega-3 intake, depressive 
symptoms, and perceived stress between nicotine dependent smokers and non-nicotine dependent 
smokers. 
 
IV. Results 
Subject Characteristics: 
The primary study examined 136 African American and Caucasian male or female 
bioconfirmed smokers 18-50 years of age who identified themselves as a person who has smoked 
10-40 cigarettes/day for at least one year. There were 108 complete data sets used in this 
secondary analysis. In this sample, about half of the participants were female and 45% African 
American. The mean age was 28.3 years. Participants smoked an average of 15.7 cigarettes per 
day and had an average baseline cotinine level of 218.7 ng/mL. Time to first cigarette ranged from 
1.0 minutes to 99.0 minutes, with an average of 21.8 minutes. The participants had an average body 
mass index (BMI) of 27.8 and average educational level was 12.9 years. The Vio Food Frequency 
Questionnaire indicated an average omega-3 intake of 2.32 grams/day and an average tryptophan 
intake of 1.29 grams/day among the subjects. CES-D scores ranged from 3 to 43, with an average 
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score of 14 points. Perceived Stress scores ranged from 12 to 33 with an average score of 21.2 
(See Table 1). It was noted that omega-3 intake, tryptophan intake, pyridoxine intake, and niacin 
intake were positively skewed. Correcting for skewness by taking the square root or log of the 
variables did not significantly change the correlation and regression analyses. Results reported are 
with untransformed data. 
Table 1: Demographic and Clinical Characteristics of Sample (N=108) 
 
VARIABLE 
 
SAMPLE CHARACTERISTIC  
Mean (SD) 
 
RANGE 
 
Age (yrs) 
 
 
28.3 (8.3) 
 
18-50 
 
Gender (%Female) 
(% Male) 
 
 
46.3 
53.7 
 
 
---- 
 
Race (% Caucasian) 
(% African American) 
 
55.6 
44.4 
 
 
---- 
 
Average education (yrs) 
 
12.9 (1.7) 
 
 
9.0-17.0 
 
Average Body Mass Index (BMI) 
 
 
27.8 (7.7) 
 
18.1-57.5 
 
Cigarettes per day 
 
 
15.7 (6.2) 
 
4.0-40.0 
 
Average baseline Cotinine (ng/mL) 
 
218.68 (128.94) 
 
 
19.0-695.0 
 
Time to first cigarette (TTF in minutes) 
 
 
22.78 (21.28) 
 
1.0-99.0 
 
Average CES-D score 
 
14.02 (7.52) 
 
 
3.0-43.0 
 
Perceived stress score (PSS) 
 
 
21.22 (3.95) 
 
12.0-33.0 
 
Average omega-3 intake (g/day) 
 
2.32 (1.66) 
 
 
0.25-9.90 
 
Average tryptophan intake (g/day) 
 
1.29 (.98) 
 
 
0.17-5.43 
 
Average pyridoxine intake (mg/day) 
 
2.71 (2.15) 
 
 
0.37-12.87 
 
Average niacin intake (mg/day) 
 
32.31 (25.52) 
 
 
5.62-138.59 
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Depressive Symptoms and Tryptophan 
 Pearson’s correlation was used to determine if a relationship exists between depressive 
symptoms and tryptophan intake among the 108 participants (Aim 1).  Because pyridoxine is needed 
for the production of tryptophan and increased niacin intake allows for more production of serotonin, 
both pyridoxine and niacin intake were taken into consideration when running correlation statistics. 
Controlling for pyridoxine and niacin intake, Pearson’s correlation between tryptophan and CES-D 
scores is -.109 (See Table 2).  The relationship is inverse, indicating increased depressive 
symptoms with low intake of tryptophan; however, statistics indicate no significant relationship 
(p=.265) between CES-D scores and intake of tryptophan among the 108 subjects. 
 
Table 2: Correlation between CES-D score and tryptophan intake, controlling for pyridoxine and 
niacin intake (N=108) 
Control Variables TRYPTOPHAN CESDTOTAL 
Pyridoxine & 
Niacin 
TRYPTOPHAN Correlation 1.000 -.109 
Significance (2-tailed) . .265 
df 0 104 
CES-D TOTAL Correlation -.109 1.000 
Significance (2-tailed) .265 . 
df 104 0 
 
Depressive Symptoms and Omega-3 PUFAs 
 It was hypothesized that subjects would display increased depressive symptoms with 
decreased intake of Omega-3 PUFAs (Aim 2). Pearson’s correlation was used to assess this 
relationship. Pearson’s correlation for the CES-D scores and omega-3 PUFA intake is -.015 (See 
Table 3).  Again, the inverse relationship indicates increased CES-D scores with lower intake of 
omega-3 PUFAs; however, the relationship is not statistically significant (p=.881).  
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Table 3: Correlation between CES-D score and Omega-3 PUFA intake (N=108) 
  OMEGA-3 CES- D TOTAL 
OMEGA-3 Pearson Correlation 1.000 -.015 
Sig. (2-tailed)  .881 
N 108.000 108 
CES-D TOTAL Pearson Correlation -.015 1.000 
Sig. (2-tailed) .881  
N 108 108.000 
 
Smoking and Depressive Symptoms 
 Pearson’s correlation was again used to examine the relationship between depressive 
symptoms and level of smoking, which was indicated by cotinine level. Literature supports the 
hypothesis that an increased amount of depressive symptoms would be associated with higher 
baseline cotinine values. Among the sample of 108 subjects, the relationship between baseline 
cotinine values and CES-D scores has a Pearson’s correlation of -.015 (See Table 4).  With a 
significance of .895, there is no significant relationship between these two variables among the 108 
subjects. 
 
Table 4: Correlation between baseline cotinine and CES-D score (N=108) 
  CES-D TOTAL BASELINE COTININE 
CES-D TOTAL Pearson Correlation 1.000 -.015 
Sig. (2-tailed)  .889 
N 108.000 108 
BASELINE 
COTININE 
Pearson Correlation -.015 1.000 
Sig. (2-tailed) .898  
N 108 108.000 
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Smoking and Nutrition  
 Pearson’s correlation was used to examine the relationship between the subjects’ nutrition 
profiles and smoking status as indicated by baseline cotinine level. Results indicate that none of the 
selected nutritional indicators (omega-3, tryptophan, niacin, vitamin B6, fat, and calories consumed) 
were significantly correlated with smoking status (see Table 5).  
 
Table 5: Correlation between smoking status and selected nutrients (N-108) 
 
Correlations 
  Baseline 
Cotinine Omega-3 Tryptophan Niacin Vitamin B6 
Baseline Cotinine  Pearson Correlation 1.000 .114 .042 .003 -.023 
Sig. (2-tailed)  .242 .665 .976 .816 
N 108.000 108 108 108 108 
Omega-3 Pearson Correlation .114 1.000 .852
**
 .784
**
 .759
**
 
Sig. (2-tailed) .242  .000 .000 .000 
N 108 108.000 108 108 108 
Tryptophan Pearson Correlation .042 .852
**
 1.000 .937
**
 .882
**
 
Sig. (2-tailed) .665 .000  .000 .000 
N 108 108 108.000 108 108 
Niacin Pearson Correlation .003 .784
**
 .937
**
 1.000 .957
**
 
Sig. (2-tailed) .976 .000 .000  .000 
N 108 108 108 108.000 108 
Vitamin B6 Pearson Correlation -.023 .759
**
 .882
**
 .957
**
 1.000 
Sig. (2-tailed) .816 .000 .000 .000  
N 108 108 108 108 108.000 
**. Correlation is significant at the 0.01 level (2-tailed).    
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Predictors of Depression 
 Multiple regression was used to analyze the multiple hypothesized, independent predictor 
variables of depressive symptoms (Aim 3). Again, pyridoxine and niacin intake were taken into 
consideration when describing tryptophan intake. Of the three hypothesized predictors of 
depression, omega-3 intake, tryptophan intake, and baseline cotinine level, there was no significant 
data supporting that these variables could adequately predict increased depressive symptoms in the 
sample. Levels of significance are displayed in Table 6. 
 
Table 6: Potential predictors of depressive symptoms (N=108) 
 
Stress and Depression 
 According to Cohen (1983), higher scores on the PSS are associated with increased 
perceived stress and scores are also associated with depressive symptomatology. Pearson’s 
correlations were used to assess the relationship between the CES-D score and the PSS score 
among the 108 participants. Results indicate that CES-D score and PSS score are highly correlated 
(p<.001). Results are displayed in Table 7.  
Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. 
95% Confidence Interval 
for B 
B Std. Error Beta 
Lower 
Bound 
Upper  
Bound 
1 (Constant) 13.973 1.762  7.928 .000 10.477 17.468 
PYRIDOXINE -.256 1.212 -.073 -.211 .833 -2.659 2.147 
NIACIN .118 .137 .400 .861 .391 -.154 .389 
OMEGA-3 -.195 .872 -.043 -.224 .824 -1.924 1.534 
TRYPTOPHAN -2.066 2.601 -.270 -.794 .429 -7.225 3.093 
BASELINE 
COTININE 
2.910E-5 .006 .000 .005 .996 -.012 .012 
a. Dependent Variable: CESDTOTAL      
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Table 7: Correlation between CES-D score and PSS score (N=108) 
 
Correlations 
  CESDTOTAL PSS 
CES-D TOTAL Pearson Correlation 1 .519
**
 
Sig. (2-tailed)  .000 
N 108 107 
PSS Pearson Correlation .519
**
 1 
Sig. (2-tailed) .000  
N 107 107 
 
Stress, Nicotine Dependence, Depression and Nutrition 
Another aim of this study was to determine if there is a significant difference in tryptophan 
intake, omega-3 intake, depressive symptoms, and perceived stress between nicotine dependent 
smokers and non-nicotine dependent smokers (Aim 4). Nicotine dependence was defined by 
smoking the first cigarette of they day within 30 minutes of arising. Because 87 of the 108 
participants smoked their first cigarette of the day within 30 minutes of arising, Mann-Whitney tests 
were used to determine if there was a significant difference in nutrient intake, stress and depression 
between the group that smoked within 30 minutes of arising and the group that did not. Results 
indicate that the nicotine dependent smokers consumed lower levels of tryptophan (p=.018) and 
higher PSS scores (p=.058). Mann-Whitney tests are displayed in Table 8.  
 
Table 8: Differences in tryptophan intake, omega-3 intake, CES-D scores, and PSS scores between 
nicotine dependent smokers (TTF<30 min) and non-nicotine dependent smokers (TTF>30 min) 
(N=107 for PSS and 108 for tryptophan, omega-3, and CES-D total) 
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Ranks 
 TTF N Mean Rank Sum of Ranks 
PSS 1.00 (Before 30 min) 86 51.20 4403.00 
2.00 (After 30 min) 21 65.48 1375.00 
Total 107   
TRYPTOPHAN 1.00 (Before 30 min) 87 50.99 4436.00 
2.00 (After 30 min) 21 69.05 1450.00 
Total 108   
OMEGA-3 1.00 (Before 30 min) 87 53.37 4643.00 
2.00 (After 30 min) 21 59.19 1243.00 
Total 108   
CES-D TOTAL 1.00 (Before 30 min) 87 52.78 4591.50 
2.00 (After 30 min) 21 61.64 1294.50 
Total 108   
Baseline Cotinine 1.00 (Before 30 min) 87 58.67 5104.50 
2.00 (After 30 min) 21 37.21 781.50 
Total 108   
 
 
Test Statistics
a
 
 PSS TRYPTOPHAN OMEGA3 CESDTOTAL CotBase 
Mann-Whitney U 662.000 608.000 815.000 763.500 550.500 
Wilcoxon W 4403.000 4436.000 4643.000 4591.500 781.500 
Z -1.898 -2.371 -.765 -1.166 -2.818 
Asymp. Sig. (2-tailed) .058 .018 .444 .244 .005 
a. Grouping Variable: TTF 
 
 
Sociodemographics, smoking level, BMI, depressive symptoms, and nutrition  
 
 A secondary aim of this study was to explore the relationship between sociodemographics, 
smoking level, body mass index, depressive symptoms, and nutritional intake. 
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Sociodemographics and Depressive Symptoms 
 Pearsons correlation was used to examine the relationship between sociodemographics and 
depression rating on the CES-D questionnaire. The variables selected included age at which the 
subject began smoking, years of education, gender, race, and age at the time of the study. Of these 
variables, level of education was the only variable that was significantly correlated with CES-D score 
(p=.076). The negative, low correlation implies an inverse relationship between education level and 
CES-D scores, indicating that subjects with lower levels of education exhibited higher scores on the 
CES-D, implying increased depressive symptoms.  
 In addition, age was positively correlated with race (p=.001), indicating that the older 
participants were generally African American. Years of education was also significantly correlated 
with race (p=.002). This inverse correlation implies that the Caucasian participants generally had 
higher levels of education (See Table 9). 
 
Table 9: Correlation between sociodemographics variables and CES-D score (N=108) 
 
Correlations 
  GENDER CES-D TOTAL AGE RACE EDUCATION 
GENDER Pearson Correlation 1 .140 -.095 -.046 .017 
Sig. (2-tailed)  .149 .327 .639 .862 
N 108 108 108 108 108 
CES-D TOTAL Pearson Correlation .140 1 -.039 .148 -.171 
Sig. (2-tailed) .149  .688 .127 .076 
N 108 108 108 108 108 
AGE Pearson Correlation -.095 -.039 1 .365
**
 .047 
Sig. (2-tailed) .327 .688  .000 .632 
N 108 108 108 108 108 
RACE Pearson Correlation -.046 .148 .365
**
 1 -.290
**
 
Sig. (2-tailed) .639 .127 .000  .002 
N 108 108 108 108 108 
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EDUCATION Pearson Correlation .017 -.171 .047 -.290
**
 1 
Sig. (2-tailed) .862 .076 .632 .002  
N 108 108 108 108 108 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
 
BMI and Gender 
 Another area of interest was the relationship between BMI and gender. Using independent 
sample t-tests, there is a significant difference in body mass index between genders (p=.026), 
implying that the female participants had higher body mass indexes than male participants (See 
Table 10). 
 
Table 10: Differences in BMI among genders (N=108) 
 
Group Statistics 
 Gender N Mean Std. Deviation Std. Error Mean 
BMI 1 (Male) 58 26.04823 5.911377 .776202 
2 (Female) 50 29.39400 9.331304 1.319646 
 
Independent Samples Test 
  Levene's Test for 
Equality of Variances t-test for Equality of Means 
  
  
95% Confidence 
Interval of the 
Difference 
  
F Sig. t df 
Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference Lower Upper 
BMI Equal variances 
assumed 
10.455 .002 -2.256 106 .026 -3.345775 1.482833 -6.285635 -.405914 
Equal variances 
not assumed 
  
-2.185 80.488 .032 -3.345775 1.530998 -6.392274 -.299276 
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Age and Smoking Status 
 
 Another area of interest involved the relationship between subject’s ages, baseline cotinine, 
age at which the subjects began smoking, and number of cigarettes smoked per day. Pearson’s 
correlation was used to examine the relationship between these four variables. Analyses indicate 
that baseline cotinine was positively correlated with age (p=.002), implying that cotinine values 
generally increased with age. Because cotinine baseline is indicative of level of smoking, the 
significant, moderate positive relationship between cotinine and number of cigarettes per day was 
expected (p=.001). In addition, age was also significantly correlated with number of cigarettes per 
day. This reiterates the notion that, in general, number of cigarettes smoked per day increased with 
age (p=.001). The age at which the subject began smoking was inversely correlated with number of 
cigarettes smoked per day (p=.025), indicating that the sooner the subjects began smoking, the 
more cigarettes they currently smoke per day (see Table 8). 
Table 8: Correlation between subject ages, baseline cotinine, age at which the subjects began 
smoking, and number of cigarettes smoked per day (N=108) 
Correlations 
  COTININE 
BASELINE AGE 
AGE 
BEGAN 
CIGS PER 
DAY 
COTININE 
BASELINE 
Pearson Correlation 1.000 .293
**
 -.079 .403
**
 
Sig. (2-tailed)  .002 .418 .000 
N 108.000 108 108 108 
AGE Pearson Correlation .293
**
 1.000 .112 .196
*
 
Sig. (2-tailed) .002  .250 .042 
N 108 108.000 108 108 
AGE BEGAN Pearson Correlation -.079 .112 1.000 -.216
*
 
Sig. (2-tailed) .418 .250  .025 
N 108 108 108.000 108 
SMOKE PER 
DAY 
Pearson Correlation .403
**
 .196
*
 -.216
*
 1.000 
Sig. (2-tailed) .000 .042 .025  
N 108 108 108 108.000 
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Correlations 
  COTININE 
BASELINE AGE 
AGE 
BEGAN 
CIGS PER 
DAY 
COTININE 
BASELINE 
Pearson Correlation 1.000 .293
**
 -.079 .403
**
 
Sig. (2-tailed)  .002 .418 .000 
N 108.000 108 108 108 
AGE Pearson Correlation .293
**
 1.000 .112 .196
*
 
Sig. (2-tailed) .002  .250 .042 
N 108 108.000 108 108 
AGE BEGAN Pearson Correlation -.079 .112 1.000 -.216
*
 
Sig. (2-tailed) .418 .250  .025 
N 108 108 108.000 108 
SMOKE PER 
DAY 
Pearson Correlation .403
**
 .196
*
 -.216
*
 1.000 
Sig. (2-tailed) .000 .042 .025  
N 108 108 108 108.000 
**. Correlation is significant at the 0.01 level (2-tailed).   
*. Correlation is significant at the 0.05 level (2-tailed).   
 
 
Race and Smoking Status 
 Kendall’s tau b was used to examine the correlation between race and cigarettes per day. In 
general, race was inversely correlated with cigarettes per day (p=.045) and positively correlated with 
baseline cotinine (p=.004). This indicates that African American subjects smoked fewer cigarettes 
per day and had higher baseline cotinine levels compared to their Caucasian counterparts (See 
Table 9). 
 
Table 9: Correlation between level of smoking and race (N=108) 
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Correlations 
   BASELINE 
COTININE 
CIGS PER 
DAY RACE 
Kendall's tau b BASELINE 
COTININE 
Correlation Coefficient 1.000 .282
**
 .227
**
 
Sig. (2-tailed) . .000 .004 
N 108 108 108 
CIGS PER 
DAY 
Correlation Coefficient .282
**
 1.000 -.171
*
 
Sig. (2-tailed) .000 . .045 
N 108 108 108 
RACE Correlation Coefficient .227
**
 -.171
*
 1.000 
Sig. (2-tailed) .004 .045 . 
N 108 108 108 
**. Correlation is significant at the 0.01 level (2-tailed).   
*. Correlation is significant at the 0.05 level (2-tailed).   
 
 
Sociodemographic Variables and Nutrition (omega-3, niacin, pyridoxine, and tryptophan) 
 Kendal’s tau b was used to examine the relationship between sociodemographics variables 
(gender, age, race, and level of education) and nutritional intake. Gender was significantly inversely 
correlated with niacin, vitamin B6, and tryptophan, indicating that males consumed higher levels of 
these nutrients than females. In addition, age was significantly positively correlated with omega-3 
intake, indicating that omega-3 consumption increased with age (See Table 10). 
 
Table 10: Correlation between sociodemographics and selected nutrients 
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IV. Discussion and Conclusions 
In summary, Pearson’s correlations among the 108 African American and Caucasian male 
and female cigarette smokers indicated a non-significant inverse relationship between smoking and 
tryptophan and smoking and omega-3 intake, and there was no significant relationship between 
smoking, depressive symptoms, and the selected nutrients. Neither nutrient intake nor smoking 
could predict depressive symptoms. Less education was correlated with higher CES-D scores 
(p=.046) and Caucasians had higher levels of education (p=.001). Females had higher body mass 
indexes (p=.034). Older subjects had higher baseline cotinine levels (p=.002) and smoked more 
cigarettes per day (p=.042).  African Americans had higher baseline cotinine levels (p=.004), and 
smoked more cigarettes per day (p=.045). 
 
Tryptophan and Depressive Symptoms 
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Previous studies have indicated an inverse correlation between tryptophan levels and 
depression, with smoking exacerbating this relationship (Booij et al, 2005; Spring et al, 2007; 
Pergadia et al, 2004). The results from this study are similar to these previous studies in identifying 
this potential inverse relationship, implying that increased depressive symptoms are associated with 
low intake of tryptophan; however, statistics indicate no significant relationship (p=.265) among the 
108 subjects. Despite these insignificant findings, the potential relationship still remains biologically 
plausible due to the fact that serotonin production is dependent upon tryptophan and niacin intake. 
All previous studies have examined this inverse relationship between tryptophan and depressive 
symptoms through the use of acute tryptophan depletion (Booij et al, 2005; Spring et al, 2007; 
Pergadia et al, 2004), which was not an option in this current study.  In addition, all previous studies 
have controlled tryptophan intake, while this study examined the subjects’ self-reported intake over 
the past 90 days via the Vio Food Frequency Questionnaire.  
 
Smoking and Depressive Symptoms 
 This study also shows no relationship between smoking, defined as baseline cotinine level 
and cigarettes per day, and depression, despite the results of numerous studies that indicate the 
high correlation among these variables (Son et al, 1997; Brown et al, 2000; Kenny et al, 2006). 
Although the CES-D score was the selected tool for many of the previous studies that examined the 
relationship between smoking and depressive symptoms, many of the reviewed studies used a 
nicotine dependence questionnaire in addition to baseline cotinine levels to define smoking level. 
When nicotine dependence was taken into consideration in these studies, the dependent smokers 
displayed significantly higher CES-D scores (Son et al, 1997; Brown et al, 2000; Kenny et al, 2006).  
 In addition, the subjects’ CES-D scores range from 3 to 43, with a score of 16 indicating 
depressive symptoms. Many studies have established the high correlation between smoking and 
depression; however, in order to examine this relationship with other variables, it is important to have 
depressed subjects. Of the 108 participants, 69 subjects (63.9% of the sample), had reported CES-D 
scores less than 16. This emphasizes the notion that the 108 participants may not adequately 
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represent the true incidence of depressive symptoms in the smoking population. In addition, 
previous studies have compared large samples of both smokers and nonsmokers when establishing 
this relationship. For example, a total of 671 women with no history of major depressive disorders 
were studied by researchers at the University of Melbourne. Of the women who were smokers, 15% 
went on to develop major depressive disorder. However, among non-smokers, only 6.5% developed 
major depressive disorder during a decade of follow-up (University of Melbourne, 2008).  
 
Omega-3 PUFAs and Depressive Symptoms 
The relationship observed between omega-3 PUFAs and depressive symptoms among the 
108 subjects was not statistically significant (p=.881). Previous studies have indicated an inverse 
relationship between serum levels of PUFAs and depressive symptoms. Despite the statistical 
insignificance observed in this study, the correlation between these two variables remains 
biologically plausible due to the fact that fatty acids inhibit pro-inflammatory cytokine synthesis, 
which is associated with depression, by suppressing inflammation and immune reactivity markers 
(Mamalakis et al, 2006). While the Vio Food Frequency Questionnaire is a validated approach for 
estimating types and quantities of foods consumed over the past 90 days (Patterson et al, 1999), no 
previous studies were found that used self report in examining the relationship between omega-3 
PUFAs and depressive symptoms. Instead, previous studies have used adipose tissue aspiration 
and serum levels, which provides for a more exact estimation of omega-3 intake (Mamalakis et al, 
2006; Keicolt-Glaser et al, 2007). 
 
Smoking and Selected Nutrients   
 Results from this study also imply no relationship between omega-3, tryptophan, niacin, 
vitamin B6 and smoking level. Previous studies demonstrated an inverse relationship between 
smoking status and omega-3 fatty acid intake because cigarette smoke negatively affects omega-3 
fatty acid synthesis. In addition cigarette smoke decreases PUFA synthesis because of the free 
radicals that result from smoking (Pawlosky et al, 2007; Marangoni et al, 2004). In this study, all 
Nutrition and Depression 34 
nutrient variables were measured via the Food Frequency Questionnaire; therefore serum nutrient 
levels were not available. It was hypothesized that the 108 participants would exhibit decreased 
intake of the selected nutrients because the most comprehensive study that has examined the 
relationship between smoking and nutrition indicated that smokers have less than adequate dietary 
intakes of a variety of nutrients when compared to nonsmokers (Dyer et al, 2003).  While the 
reported levels of nutrients could not be compared to nonsmokers, the Vio Food Frequency 
Questionnaires of all 108 subjects indicated adequate tryptophan, omega-3, vitamin B6, and niacin 
intake among all the 108 subjects as defined by the Food and Nutrition Information Center of the 
United States Department of Agriculture National Agricultural Library (United States Department of 
Agriculture, 2002).  
 
Predictors of Depression 
Although previous research indicated associations between smoking and nutrition, and 
smoking and depressive symptoms, no research was found that integrated all three of these 
variables. Of the three hypothesized predictors of depression, omega-3 intake, tryptophan intake, 
and baseline cotinine level, there was no significant data supporting that these variables could 
adequately predict increased depressive symptoms in the sample of the 108 participants. Because 
the correlations were low among the hypothesized variables, the regression data was likely to be 
insignificant. Again, serum nutrient levels would have provided better indication of nutrient intake.  
 
Stress, Nicotine Dependence, Depression and Nutrition 
Results indicated that nicotine dependent smokers, the smokers who smoked their first 
cigarette within 30 minutes of awakening, had higher perceived stress (p=.058) and lower tryptophan 
intake (p=.018). From a biological perspective, serotonin is a neurotransmitter that is synthesized 
from tryptophan, an essential amino acid that must be ingested. The Booij et al (2005) study 
supports this notion that low levels of tryptophan ultimately deplete serotonin and diminished 
serotonin levels are highly associated with depression. However, the Booij et al study looked at this 
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relationship by purposefully depleting tryptophan in the participants.  The Spring, et al (2007) study 
also depleted tryptophan levels in their participants, but they added the smoking variable. 
Researchers reported that smoking magnified the depressive symptoms in subjects with low 
tryptophan levels. 
This study is the first known study to look at the differences between tryptophan intake, 
perceived stress, and depressive symptoms among nicotine dependent and non-nicotine dependent 
smokers. While significant differences were found, there are some limitations to this data. 
Tryptophan intake was assessed via self-report and the PSS and CES-D are also subjective tools. In 
addition, a majority of the subjects smoked a cigarette within 30 minutes of awakening (n=87), so 
non-parametric statistics were used to assess these differences. 
 
Sociodemographics, smoking level, BMI, depressive symptoms, and nutrition  
 
 A secondary aim of this study was to explore the relationship between sociodemographics, 
smoking level, body mass index, depressive symptoms, and nutrition. Among the sociodemographic 
data, level of education was the only variable that was significantly correlated with CES-D score (r= -
.171, p=.076). The negative, low correlation implies an inverse relationship between education level 
and CES-D scores, indicating that subjects with lower levels of education exhibited higher scores on 
the CES-D. Years of education was also significantly correlated with race (r= -.290, p=.002). The 
inverse correlation implies that the Caucasian participants generally had higher levels of education. 
African Americans typically had lower education levels; however, there was no correlation of 
depression and race. Despite this, the association of education level and depressive symptoms 
could be attributed to a variety of factors, including the economic stressors that may result from 
having a lower level of education. These findings are congruent with a recent study that showed that 
smoking and low education levels were predictors of depression (Rubio, et al., 2008). Despite this, 
further research regarding the relationship between level of education and depression needs to be 
completed in order to further investigate factors associated with less education that contribute to 
depressive symptoms in adults, specifically adults who smoke. 
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 Another area of significance was the relationship between BMI and gender. The low positive 
correlation between body mass index and gender implies that the female participants had higher 
body mass indexes than male participants. Despite this, gender was significantly inversely correlated 
with niacin, vitamin B6, and tryptophan, indicating that males consumed more of these nutrients than 
females. Further research is needed to assess these relationships; however, the higher BMI in 
females can be indicative of severe health problems, such as cardiovascular disease and diabetes 
mellitus. The American Heart Association recommends that all adults increase their consumption of 
omega-3 fatty acids because of the increased risk of developing coronary artery disease that is 
associated with omega-3 deficiency (He et al, 2004). These preliminary results indicate that further 
research is needed to investigate this risk among the female smoking population.  
In addition, analyses indicate that baseline cotinine was positively correlated with age 
(r=.293, p=.002). In addition, age was significantly correlated with number of cigarettes per day 
(r=.196, p=.042). The moderate correlation between number of cigarettes per day and baseline 
cotinine (r=.403, p=.001) validates the use of baseline cotinine in measuring level of smoking. To 
further validate the relationship between age and level of smoking, the age at which the subject 
began smoking was inversely correlated with number of cigarettes smoked per day, indicating that 
the sooner the subjects began smoking, the more cigarettes they currently smoke per day. This is 
particularly significant because serum cotinine level has been found to be a predictor of risk of lung 
cancer among smokers (Boffetta
 
et al, 2006). This means that higher baseline cotinine levels put 
people at a higher risk of developing lung cancers. Because cigarette smoking is highly addictive, 
the older participants are more vulnerable when it comes to health status.  
Another area of significance was the relationship between race and smoking level. Race was 
inversely correlated with cigarettes per day and positively correlated with baseline cotinine. This 
implies that African American subjects smoked fewer cigarettes per day, but yet had higher baseline 
cotinine levels. This data indicates that the African American participants in the study had more 
cotinine, a nicotine metabolite, in their system despite the fact that they smoke fewer cigarettes per 
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day. These findings are consistent with existing criterion in which African American subjects smoke 
fewer cigarettes per day and have higher baseline cotinine levels.  
 
Conclusions 
In summary, the findings of this study do not completely support the proposed hypothesis 
regarding the relationship between smoking level, depressive symptoms and the selected nutrients. 
It was hypothesized that smokers with increased depressive symptoms would have lower than the 
recommended levels of tryptophan and omega-3 fatty acids in their diets and that nicotine 
dependent smokers would have greater depressive symptoms, higher perceived stress, and lower 
than the recommended dietary intake of tryptophan and omega-3 fatty acids. Smokers with 
increased depressive symptoms did not have significantly lower than the recommended levels of 
tryptophan and omega-3 fatty acids in their diets; however, nicotine dependent smokers had higher 
perceived stress, greater depressive symptoms, and lower tryptophan intake.  
Despite this, more research is needed in order to further assess this relationship. The small 
sample size and secondary nature of this study limit the applicability of the findings. The self-report 
method of identifying food intake via the Food Frequency Questionnaire was a major limitation in this 
study as well as the fact that the population was not compared to nonsmokers. Serum nutrient levels 
would allow researchers to accurately identify systemic nutrient levels.  
Previous studies indicated that smokers have less healthful diets than nonsmokers, are at a 
higher risk for developing depressive symptoms with low dietary intake of omega-3 PUFAs and 
tryptophan, and are at a higher risk of depressive symptoms with increased nicotine dependence 
and cotinine level. This was the first study to examine the relationship among all three variables and 
warrants further examination. Nursing interventions in smokers need to focus on smoking cessation 
as well as improving diets in the effort to reduce cancer and cardiovascular disease risks. Screening 
for depression among smokers is also an area of importance because of the high incidence of Major 
Depressive Disorder among the smoking population. This screening becomes especially important in 
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smokers who are attempting smoking cessation because smoking cessation may be less successful 
in people who exhibit depressive symptoms (Perez, et al., 2008).  
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